Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis

NCT01767701 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Raltegravir

Sponsor

Queen Mary University of London

Collaborators

[object Object]